These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8385409)

  • 1. [Tumor properties of primary tumors and local recurrence of breast cancer].
    Torsten U; Opri F; Moreno-Richter I; Weitzel HK
    Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
    Weikel W; Beck T; Rosenthal H; Herzog R
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the proliferation rate on the course of node negative breast carcinoma].
    Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [137 local recurrences after breast carcinoma--a retrospective study].
    Richter IM; Opri F; Torsten U; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):198-203. PubMed ID: 8682285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
    Rempen A; Caffier H
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases.
    Sirvent JJ; Santafé M; Salvadó MT; Alvaro T; Raventós A; Palacios J
    Histol Histopathol; 1994 Jul; 9(3):563-70. PubMed ID: 7526910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
    Ronay G; Sponsel N; Merkle E; Tulusan AH
    Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
    [No Abstract]   [Full Text] [Related]  

  • 10. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
    Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors in medullary breast cancer].
    Mitze M; Goepel E
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
    Graeff H; Jänicke F
    Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
    Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tumour characteristics and axillary lymph node status in breast cancer.
    Yiangou C; Shousha S; Sinnett HD
    Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.